Outlining the FORCE Platform: Innovations to Enhance Oligonucleotide Delivery to Muscle Tissues

• How Dyne’s Force platform is enhancing delivery of oligos to muscle tissues
• Properties and modularity of the FORCE Platform
• Provide evidence of translation between pre-clinical models and clinical proof of concept with DYNE-101

Speakers:

Tama Evron

Discovery Director, Platform

Dyne Therapeutics